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Multiple sclerosis (MS) is a chronic autoimmune, 
inflammatory neurological disease of the central 
nervous system (CNS). MS attacks the myelinated 
axons in the CNS, destroying the myelin and the axons 
to varying degrees and leads to focal areas of damage, 
axon  injury,   axon  transection,   neurodegeneration,  
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and subsequent scar or plaque formation.The course 
of MS is highly varied and unpredictable. In most 
patients, the disease is characterized initially by 
episodes of reversible neurological deficits, which is 
often followed by progressive neurological 
deterioration over time. MS affects 2.5 million 
individuals worldwide. It is approximately threefold 
common in women than men and the age of onset is 
typically between 20 and 40 years, but the disease can 
present across the life span. MS also correlates with 
high socioeconomic status. MS was uncommon in 
Indian subcontinent, but the widespread availability 




The cause is unknown, but the risk factors include a 
combination of genetic susceptibility and a 
nongenetic trigger, such as a virus, vitamin D 
deficiency or environmental factors, that together 
result in a self-sustaining autoimmune disorder that 
leads to recurrent immune attacks on the CNS. 
A B S T R A C T  
Autoimmune disease occurs when the immune system attacks self-molecules as a result of a 
breakdown of immunologic tolerance to autoreactive immune cells. Autoimmune disorders are on the 
rise globally and affect 8.5% of the population worldwide. Multiple sclerosis (MS), the most prevalent 
neurological disability is an autoimmune disease of Central nervous system characterized by chronic 
inflammation, demyelination, gliosis and neuronal loss. Although the aetiology and pathogenesis of MS 
remains unclear, several studies illustrate that the cause of MS is multifactorial and include genetic 
predisposition together with environmental factors. Therapies for MS are based on the use of anti-
inflammatory and immunomodulatory drugs, but these treatments are not able to stop the destruction 
of nerve tissue. Hence a comprehensive management programme is strongly recommended for all 
patients with multiple sclerosis, enhancing health-related quality of life through advocating wellness, 
addressing aggravating factors, and managing comorbidities. Multiple Sclerosis can be understood as 
anuktavata vyadhi based on similarity of symptoms as there is no direct correlation in Ayurvedic 
classics. With immunosuppressant or cortico-steroids as only available treatment in modern sciences, 
Ayurveda can be ray of hope. The scope of Ayurvedic Management and preventive aspects mainly 
concentrates on improving the quality of life and decrease dependency by patients on others. Hence 
here an attempt is made to analyse the disease and its management. 
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Pathogenesis 
Predisposing factors such as genetic, environmental 
and infection triggers the activation of myelin-reactive 
Th1/17 cells due to which there will be infiltration in 
CNS further leading to blood brain barrier breakdown. 
As a result, immune cell recruitment occurs causing 
CNS tissue damage and neurological dysfunction will 
be seen. 
Types of Multiple Sclerosis 
Types of MS are considered important not only for 
prognosis but also for treatment decisions and 
include: Relapsing remitting MS (RRMS), Primary 
progressive MS (PPMS), Secondary progressive MS 
(SPMS), and Progressive relapsing MS (PRMS) 
 Relapsing/remitting MS (RR-MS) 
Relapsing/remitting MS (RRMS) accounts for85% of 
MS cases at onset and is characterized by discrete 
attacks that generally evolve over days to weeks 
(rarely over hours). With initial attacks,there is often 
substantial or complete recovery over the ensuing 
weeks to months,but as attacks continue over time 
recovery may be less evident. Between attacks 
patients are neurologically stable 
 Secondary-progressive MS (SP-MS) 
Secondary-progressive MS (SPMS)always begins as 
RRMS.At some point, however, the clinical course 
changes so that the patient experiences a steady 
deterioration in function unassociated with acute 
attacks.For a patient with RRMS, the risk of 
developing SPMS is ~2.5%each year 
 Primary-progressive MS (PP-MS) 
Primary-progressive MS (PPMS) accounts for ~ 15% of 
cases. These patients do not experience attacks but 
only a steady functional decline from disease onset. 
 Progressive/relapsing MS (PR-MS) 
Progressive/relapsing MS (PR-MS) accounts for ~ 5% 
of cases. These patients experience a steady 
deterioration in their condition from disease onset 
along with occasional attacks superimposed upon 
their progressive course.
[2] 






































Unsteady gait and 
slurred speech 
 





Unilateral visual loss 


















 No definitive diagnostic test for Multiple sclerosis 
 Two or more episodes of symptoms and two or 
more signs that reflect pathology in anatomically 
noncontiguous white matter tracts of the 
CNS(Diagnostic criteria for multiple sclerosis 2010 
–McDonald criteria) 
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Investigations 
 MRI scans of the brain and spinal cord, which may 
reveal lesions 
 Spinal fluid analysis, which may identify 
antibodies that suggest a previous infection 
 Evoked potential test, which measures electrical 
activity in response to stimuli 
Treatment  
Therapy for MS can be divided into three categories  
1. Treatment of acute attacks  
2. Treatment with disease modifying agents that 
reduce the biologic activity of MS  
3. Symptomatic therapy. 
Treatments that promote remyelination or neural 
repair do not currently exist. The Common side 
effects include headache, diarrhoea, back pain, cough, 
and abnormal liver tests and may lead to progressive 





In MS, the immune system attacks the protective 
sheath (myelin sheath), which is a lipid-rich (fatty) 
substance that surrounds nerve cell axons can be 
understood as Snayu formed from medas 
(medasahasnayusambhavaha).
[5]
 The explanation 
which resemble multiple sclerosis is not accessible 
specifically as separate disease entity in any of the 
major Ayurvedic texts. Any disease related to nervous 
system of the body can be considered in the umbrella 
of ‘Vata Vyadhi’. Vata dosha having its main lakshana 
as gati (movement) and gandhana (knowledge 
perception) are generally attributed to nervous 
system of contemporary science exhibiting the same 
functional properties. Among tridoshas the 
supremacy of vata is explained by all our Acharyas as 
“pittam phangu kapham phangu phangavo mala 
dhatavah, Vayuna yatra niyante tatra gacchati 
meghavat”.
[6]
 Vata when unvitiated holds up the  
systems and organs, initiates movements, leads and 
controls mind, helps in proper functioning of organs, 
carries sense objects. So, when this vayu become 
vitiated, it leads to abnormal condition.
[7]
 
Nidana and Samprapti 
The nidana can be either dhatu kshaya or aavarana 
leading to its respective pathogenesis.
[8]
 In dhatu 
kshaya condition vatakara Nidana Sevana produces 
Vata Prakopa.
[9]
 The concept of autoimmunity can be 
understood under the purview of aama which leads to 
aavarana and later dhatu kshaya. Aama is 
incompletely digested metabolic substances. At an 
early stage Ama can be easily cured, but as this 
condition persists for an extended period of time it 
hinders the physiological channels of the body, slows 
down the metabolism that result again in more 
production of Ama. In the initial phase, when the Ama 
is in the larger body channels, body try an alternative 
way to get rid of the toxins. However, in case of 
chronic conditions or if there are repeated 
suppression of Ama, toxins get accumulated deep in 
the cells and when the level of tissue has penetrated, 
immune system starts to attack the affected cells. This 
causes inflammation or allergic reactions that without 




Nidana sevana → Dhathu kshaya and Margavarana → 
leads to Vataprakopa → causes Sthanasamshraya in 
Snayu → and causes Vatavyadhi. 
The lakshanas of vatavyadhi are Sankocha 
(contraction), stambhana (stiffness), shoola (pain) in 
the joints as well as in bones, graha (spasticity) of 
hands, back, Khanja (lameness) and pangulya (total 
paralysis of leg) and kubjata (lunch-back), sosha 
(atrophy) of body parts, anidra (insomnia), Spandana 
(trembling of body), gatrasuptata (numbness), bheda 
(breaking pain), toda (pricking pain), akshepaka 
(convulsion), kampana (trembling), anaha (flatulence), 
malaparodha (obstruction to faeces), balaindriya 
bhramsa (loss of strength and sensory function), 
pralapa (incoherent talk), bhrama (giddiness) and 
various other symptoms based on hetu and sthana.
[11]
 
The inherent natural qualities and actions of vata such 
as roukshya (roughness), gati (movement), 
anavasthithatvam (instability) are obviously 
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manifested partially or wholly which helps to diagnose 
the vatika type of disorders. Based on these qualities 
and actions of vata the disease can be classified under 
the heading of vatavyadhi even though if it has not 
been specified as vatavyadhi.
[12] 
As multiple sclerosis 
cannot be compared to any predescribed condition in 
Ayurveda it can be considered as anukta vatavyadhi. 
Chikitsa 
The chikitsa to be based on the cause whether it is 
due to dhatu kshaya or aavarana. 
Dhatu Kshayajanya Vatavyadhi Chikitsa
[13]
 
 Snehana - bahya - abhyanaga, abhyanatara - 
snehapana 
 Snehapoorvaka Swedana - Mashapinda Sweda, 
Shashtikashali Pinda Sweda, Nadi Sweda, Prastara 
and Sankara Sweda. 
 Mridushodhana - Snigdha Virechana 
 Basti - Yapanabasti. 




Treatment of Avarana should aim towards cleansing 
the srotas with different medicaments which possess 
Anabhishyandi, Snigdha, Kaphapitta Aviruddha and 
vatanulomana property. Administration of Yapanbasti, 
Sramsanachikitsa and Rasayandravya may be 
considered after analyzing the bala of patient and the 
stage of disease. Different varieties of Panchakarma 
treatments are planned in order to remove the 
obstruction and bring Vata to its own path. 
 Maasthiskya chikitsa - Murdhni Taila i.e. 
Shirobasti, shiropicchu, shirodhara, shiro 
abhyanga and  Shiro thalam can be adopted.
[15]
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Swarna malinivasantha rasa 
DISCUSSION 
Multiple sclerosis is a potentially disabling disease of 
the central nervous system affecting the Brain, spinal 
cord and optic nerves. Medications such as steroids, 
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glucocorticoids and Interferons are advised in MS, 
however the adverse effects such as fluid retention, 
potassium loss, weight gain and hepatotoxicity are 
observed.Though there is no definite cure, treatment 
may relieve the symptoms and are partially effective. 
Multiple sclerosis is a neurological disease where 
there will be demyelination taking place. As it is a 
demyelinating disease it can be corelated to Dhatu 
Kshayajanya Vata Vyadhi. As it is a Auto immune 
disorder, the main cause for this can be taken up as 
Aama in Ayurveda and hence there may be Avarana 
pathology which may ends up with Dhatu Kshayajanya 
Vata Vyadhi. Hence it can be considered as Anukta 
Vata Vyadhi. Different treatment modalities like 
Shodhana, Shamana and Rasayana can be planned 
based on Nidana, Avastha and Lakshanas of Vyadhi. 
CONCLUSION 
The definite cause of multiple sclerosis is unknown, it 
can be understood as one among autoimmune 
diseases and there is no exact treatment protocol in 
contemporary science. Based on the symptoms it can 
be corelated to Anukta Vata Vyadhi. By adopting Vata 
Vyadhi Chikitsa we can able to prevent the further 
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